Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
188,211,491
-
Share change
-
+15,121,567
-
Total reported value
-
$51,456,575,196
-
Put/Call ratio
-
122%
-
Price per share
-
$273.42
-
Number of holders
-
1,016
-
Value change
-
+$4,118,247,453
-
Number of buys
-
465
-
Number of sells
-
475
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q1 2017
As of 31 Mar 2017 BIOGEN INC. - COM (BIIB) had 1,016 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 188,211,491 shares of stock of the company.
Largest 10 holders included BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, STATE STREET CORP, Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Invesco Ltd., and JPMORGAN CHASE & CO.
This table shows 1,017 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.